| |
KOMISJA NADZORU FINANSOWEGO |
|
| |
|
|
Raport bieżący nr |
6 |
/ |
2020 |
|
|
|
| |
Data sporządzenia: |
2020-02-12 |
|
|
|
|
|
|
|
|
|
| |
Skrócona nazwa emitenta |
|
|
|
|
|
|
|
|
|
| |
MILESTONE MEDICAL |
|
| |
Temat |
|
|
|
|
|
|
|
|
|
|
| |
Receiving a Notice of Allowance for European Patent Related to Peripheral Nerve Block
Instrument
|
|
| |
Podstawa prawna |
|
|
|
|
|
|
|
|
| |
Art. 17 ust. 1 MAR - informacje poufne.
|
|
| |
Treść raportu: |
|
|
|
|
|
|
|
|
|
| |
The Board of Directors of Milestone Medical Inc. _WAR: MMD, “the Company", “the Issuer"_,
today announced that Milestone Scientific, Inc. _NYSE:MLSS_, the licensor and the
majority shareholder of the Issuer has received Notice of Allowance from the European
Patent Office _EPO_ covering its instrument for performing a peripheral nerve block
_PNB_. The CompuFlo® with Dynamic Pressure Sensing technology® is the only available
device capable of precisely measuring, displaying, warning, controlling and recording
needle tip pressure in real time to help reduce the risk of needle injury during PNB
procedures, as recently stated by a world authority.
The Board of Directors of the Company is pleased to announce this important Notice
of Allowance from the European Patent Office covering its instrument for performing
a peripheral nerve block. This patent award follows a similar patent in United States,
and further expands the worldwide intellectual property. This instrument is designed
to significantly improve safety, efficiency and efficacy of PNB procedures. The Board
of Directors of the Company believes that PNBs represent an attractive market for
the CompuFlo® technology, as PNBs are increasingly utilized in the treatment of trauma
and surgical procedures, including orthopedic surgeries as well as for postoperative
and nonsurgical analgesia.
|
|
|
RB_ASO: Receiving a Notice of Allowance for European Patent Related to Peripheral Nerve Block
Instrument
